Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by PWIB123on Apr 07, 2022 4:50pm
88 Views
Post# 34585854

RE:2.95$ confidence building

RE:2.95$ confidence buildingWhat happened today and what has been happening for the last many months is exactly why jfm1330 is flat out wrong about his impression and interpretation of the way IR works.  I didn't think this stock could go lower and now it has.  At the rate we've been declining, it's not impossible to imagine it dropping another 20% if we get the same type of earnings call in a few days as we've seen before and no new news before end of May, this is going from worse to an absolute tragedy.  Obviously more and more investors are throwing in the towell and moving on to something else.  Who can blame them when they don't have enough information from our leadership to stay engaged?  And every day the stock drops makes it look even worse than it really is.  Because of wonder, speculation, and doubt, you see a stock dropping, you assume it's for good reason and everyone else must know something we don't.  That's true even if it's not true.  THTX management has got to get engaged in a meaningful and consistent manner.

Biobob wrote: So much excitement as we get close to MTD announcement... POS


<< Previous
Bullboard Posts
Next >>